An endlessly fascinating topic of values, many of which still go unnoticed in current research. I invite you to dive into the article for more insights: https://doi.org/10.1007/978-3-030-71869-5_20
#values #openscience #science #pharmaceuticalcompanies
An inexhaustible topic of values, not all of which are timely recognized in research. I invite you to read my colleague’s article: https://doi.org/10.1007/978-3-030-71869-5_20 #values #openscience #science #pharmaceuticalcompanies

Big Pharma's Doctor Control - Dr Jen Gunter and Doctor Mike

#pharmaceuticalcompanies #doctors

Lawsuits Claim Pfizer Failed to Warn of Brain Tumor Risk From Birth Control Shot

If Pfizer is successful, consumers may find it harder to hold drug makers accountable for inadequate warning labels.

https://murica.website/2025/10/lawsuits-claim-pfizer-failed-to-warn-of-brain-tumor-risk-from-birth-control-shot/

Lawsuits Claim Pfizer Failed to Warn of Brain Tumor Risk From Birth Control Shot – The USA Potato

“…like Pfizer, #AstraZeneca is getting a three-year reprieve on having certain tariffs levied on its pharmaceutical imports. Trump noted that the reason manufacturers are agreeing to deals is because of his tariff threats.”

The next part is extra strange 👀*

“Both companies said the details of their arrangements were confidential.”
~~

1 of 2🧵
#USA #US #USpol #healthcare #health #DrugPrices #BigPharma #PharmaceuticalCompanies #Pfizer #tariffs #trump *#MyThoughts

https://www.cnn.com/2025/10/10/politics/lower-drug-prices-trump-announcement

Eli Lilly announces weight-loss drug to be manufactured at $6.5 billion site in Houston

The multibillion-dollar investment will result in more than 600 permanent jobs, according to the company. The manufacturing hub is slated to be built at Generation Park near Lake Houston and will produce a new weight-loss drug.

Houston Public Media
Wow #RFKJr sure knows how to tattle on others. Wow so he’s admitting that #Trump also took money from the #PharmaceuticalCompanies,but then says he’s a honest man.
FDA tightens COVID-19 vaccine approval process, requiring clinical trials for ages 6 months to 64 years, potentially increasing costs for pharmaceutical companies
#YonhapInfomax #FDA #COVID19Vaccines #ClinicalTrials #PharmaceuticalCompanies #VaccineApproval #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64062
FDA Tightens COVID-19 Vaccine Approval Standards - Clinical Trials Required

FDA tightens COVID-19 vaccine approval process, requiring clinical trials for ages 6 months to 64 years, potentially increasing costs for pharmaceutical companies

Yonhap Infomax